Navigation Links
Other highlights in the September 11 JNCI
Date:9/11/2007

Nearly a third of prostate biopsies resulted in a cancer diagnosis among a population of older men on Medicare. Men whose first biopsy did not find cancer often had multiple biopsies in the future, which increased the chance of a cancer diagnosis.

While PSA (prostate-specific antigen) tests have become widely used in prostate cancer screening, a biopsy is what actually determines the presence of prostate cancer. Nonetheless, it remains unclear whether or not PSA screening actually reduces prostate cancer mortality.

H. Gilbert Welch, M.D., of the Department of Veterans Affairs Medical Center in White River Junction, Vt., and colleagues estimated the proportion of prostate biopsies that result in a cancer diagnosis and the likelihood of finding cancer with subsequent biopsies after the first one was negative. The researchers analyzed the outcomes of 10,429 biopsies performed from 1993 to 2001 in 8,273 men aged 65 and older.

About one third of prostate biopsies detected cancer, and the proportion of biopsies that found cancer increased as men got older. Among men whose first biopsy did not show cancer, about one third of them had another biopsy within five years. Nearly half of men who had a second biopsy were diagnosed with cancer, and the chance of diagnosis increased with each subsequent biopsy.

Because the goal of screening is to reduce deaths from the disease and not simply to find more cancer, the utility of [repeated biopsies warrant] careful reassessment, the authors write.

Contact: H. Gilbert Welch, h.gilbert.welch@dartmouth.edu, (802) 296-5178


Immune System Gene May Influence Lung Cancer Survival

Variations in a gene that influences the innate immune systemthe part of the immune system that provides short-term protection against infectionmay be associated with lung cancer survival.

Curtis Harris, M.D., of the National Cancer Institute in Bethesda, Md., and colleagues examined whether any of five variations of the MBL2 gene influenced survival among 558 white patients and 173 African-American patients with nonsmall-cell lung cancer.

Some gene variants were associated with improved survival among white patients, but not African-American patients. White patients who did not have the gene variants had poorer survival, particularly the heavy smokers.

This study may provide insight into the continued disparity in lung cancer survival between African-American and white patients, the authors write.

Contact: National Cancer Institute press office, ncipressofficers@mail.nih.gov, (301) 496-6641


Virus Targets Brain Cancer Stem Cells

Brain cancer stem cells are susceptible to a cancer-killing virus, which caused the death of brain tumors cells in mice and in test cells.

To achieve long-term remission, a treatment for brain cancer must kill the brain tumor stem cells that are resistant to radiation and chemotherapy.

Hong Jiang, Ph.D., of the University of Texas M.D. Anderson Cancer Center in Houston and colleagues tested whether the virus could be targeted to brain tumor cells. They were able to infect four cancer stem cell lines with the virus, which caused the cells to die. Mice with brain tumors from the cancer stem cells lived longer when they were injected with the virus than those given an inactivated version.

Our data are important because brain tumor stem cells are the driving force sustaining tumor growth, and therefore developing therapies to target the brain tumor stem cells should be a more effective strategy than conventional treatments, the authors write.

Contact: Scott Merville, external communications office, M. D. Anderson Cancer Center, sdmerville@mdanderson.org, (713) 792-0661


'/>"/>

Contact: Liz Savage
jncimedia@oxfordjournals.org
301-841-1287
Journal of the National Cancer Institute
Source:Eurekalert

Related medicine news :

1. Another ray of hope for Arthritis Sufferers
2. Another injectable contraceptive Pill approved by FDA
3. Endangered species may be successfully cloned in another animals womb
4. Acupuncture May Help Chemotherapy Side Effects
5. Spouses and other partners lower blood pressure says new research
6. Yet Another Harmful Consequence Of Smoking
7. Grandmother’s diet in pregnancy can affect grandchildren’s blood sugr
8. UK Facing Shortage of Radiotherapists Delaying Cancer Treatment
9. Radiotherapy helps in colon cancer
10. Allergies are related to mothers menses
11. Mothers with periodontitis may deliver premature babies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/20/2017)... Houston, Texas (PRWEB) , ... September 20, 2017 ... ... leader in the Orthodontics and Clear Aligner clinical and commercial support services market) ... School of Dentistry (PGSD) in Sydney, Australia. , The PGSD is the ...
(Date:9/20/2017)... ... September 20, 2017 , ... In just a short time since going ... receiving positive feedback from customers trying the product for the first time, and others ... was developed by neurosurgeon Shawn Moore, MD, for everyone from athletes at risk from ...
(Date:9/20/2017)... ... September 20, 2017 , ... ... Americans at risk of price gouging for their prescription drugs, according to a ... “Because Medicare isn’t negotiating on our behalf, there’s no consistency in drug pricing ...
(Date:9/20/2017)... ... , ... “RECYCLED Ezekiel's Plan for Freedom from ADDICTION”: A ... is the creation of published author, Bill Miller. Bill Miller has a ... more than a decade of addiction to prescription drugs. He has a ...
(Date:9/20/2017)... ... September 20, 2017 , ... “Psalms of Humidity”: is a fascinating depiction of ... the readers one step closer to God. “Psalms of Humidity” is the creation of ... have been made within his life are the very same things that have shaped ...
Breaking Medicine News(10 mins):
(Date:9/6/2017)... 6, 2017  Medical professionals are expected ... while treating their patients. Medical simulations offer ... involving patients. Simulation provides a safe method ... out procedures, refine techniques and build confidence, ... new technology, such as augmented reality, will ...
(Date:9/6/2017)... , Sept. 6, 2017 Eli Lilly ... it will present new data for galcanezumab and lasmiditan, ... of the International Headache Society (IHC) taking place Sept. ... Lilly will highlight new, long-term data from an ... doses of galcanezumab (120 mg and 240 mg) for ...
(Date:9/5/2017)... , Sept. 5, 2017  Getinge, a ... created a vibrant charitable donation program -- "Color ... support congenital heart defect research by The Children,s ... and the general public are encouraged to download ... submit the completed artwork to the gallery on ...
Breaking Medicine Technology: